50 studies found for: Open Studies | "Neurofibromatoses"
Neurofibromatosis Type 1 Patient Registry
Hypotonia and Neurofibromatosis Type 1 (NF1) Glioma
Efficacy of Computerized Cognitive Training and Stimulant Medication in Neurofibromatosis Type 1
|4||Not yet recruiting||
Vitamin D Supplementation for Adults With Neurofibromatosis Type 1 (NF1)
Photodynamic Therapy for Benign Dermal Neurofibromas
Neurofibromatosis (NF) Registry Portal
Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (PNs)
Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas That Cannot Be Removed by Surgery
Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas
Icotinib Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors
Acceptance and Commitment Training for Adolescents and Young Adults With Neurofibromatosis Type 1, Plexiform Neurofibromas, and Chronic Pain
Resiliency Training for Patients With NF2 Via Videoconferencing With Skype
Effect of Lamotrigine on Cognition in NF1
Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1
Study of Imatinib Mesylate in Neurofibromatosis Type I Patients Aged 2 to 21 With Plexiform Neurofibromas
AZD2014 In NF2 Patients With Progressive or Symptomatic Meningiomas
Targeting the Mechanisms Underlying Cutaneous Neurofibroma Formation in NF1: A Clinical Translational Approach.
A Phase II Trial of the Mitogen Activated Protein Kinase Kinase (MEK1/2) Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in Patients With Neurofibromatosis Type 1 (NF1) Mutated Gastrointestinal Stromal Tumors (GIST)
Study of RAD001 for Treatment of NF2-related Vestibular Schwannoma
Natural History Study of Patients With Neurofibromatosis Type I
† Study has passed its completion date and status has not been verified in more than two years.